Trial intelligence / Profile preview

Deep vs Moderate NMB in Laparoscopic Cholecystectomy

NCT03881423Phase 4Completed

Start
Apr 2017
Primary completion
Apr 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of rocuronium in gallbladder disease (2 arms). Primary endpoints: Surgical conditions and Quality of Recovery at 24 hours. Started Apr 2017; status: completed.

02

Drugs

rocuronium
03

Conditions

gallbladder disease

Beyond the preview

Go deeper on NCT03881423.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03881423.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call